-
-
-
-
-
-
-
Akari Therapeutics reports preclinical data on cancer drug combination
-
-
-
-
-
-
-
Akari Therapeutics gets Australian patent for ADC payload technology
-
-
-
-
-
-
-
Akari Therapeutics Announces Abstract Accepted for Poster Presentation at the American Association for Cancer Research Annual Meeting 2026
-
-
-
-
-
-
-
Akari Therapeutics Releases New CEO Corner Segment Highlighting 2025 Progress and Path to Clinical Transition In 2026
-
-
-
-
-
-
-
Akari Therapeutics Announces $5 Million Financing, Including Concurrent Registered Direct Offering and Private Placement Priced At-Market
-
-
-
-
-
-
-
Akari Therapeutics Appoints Biotech Finance Leader, Kameel D. Farag as Interim Chief Financial Officer
-
-
-
-
-
-
-
Akari Therapeutics Announces $2.5 Million Registered Direct Offering
-
1,205,335 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

